OmniAb, Inc. (OABI)

OmniAb, Inc. (OABI) is a healthcare company (biotechnology) based in the United States. The share price is $4.95, up 1.23% on the day, which values the company at $722.01M. Price as of 17 Nov 2026, 17:42 UTC, from Yahoo Finance.

Key facts

Share price
$4.95+1.23% today
Market value
$722.01M
Funk Score
22/100
Against its own history
Well above its usual priceusual price $2.61
200-week average
$3.5440% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

OmniAb, Inc. in more detail

OABI trades at -19.0× next year's expected earnings, 18.0× sales. Measured against its own history, the price is 90% above what its usual multiples would imply ($2.61) — well above its usual price. It sits 40% above its 200-week average of $3.54.

Its Funk Score is 22 out of 100 (financial strength 7.4, profitability 0.0, growth 1.3, value 0.0, each out of 10).

In its favour: Altman Z in the safe zone; More cash than debt. Worth checking: Weak Piotroski score; Share count keeps rising.

1 of the superinvestors tracked here hold OABI, including Eric Bannasch (1.7% of the portfolio).

Superinvestors holding OABI

1 of the investors tracked here report a position in their latest 13F filing.

OmniAb, Inc. (OABI): questions and answers

What is OmniAb, Inc.'s market cap?

OmniAb, Inc. is valued at $722.01M at a share price of $4.95.

Is OABI overvalued or undervalued?

Against its own history, OABI is well above its usual price: the price is 90% above the $2.61 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is OABI above its 200-week moving average?

Yes. OABI is 39.8% above its 200-week average of $3.54. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is OmniAb, Inc. growing?

Over the last three fiscal years OmniAb, Inc.'s revenue grew -31.9% a year.

Does OABI pay a dividend?

OmniAb, Inc. does not currently pay a regular dividend.

Which famous investors own OABI?

In their latest quarterly filings, Eric Bannasch (1.7% of the portfolio) hold OABI. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “OmniAb, Inc. (OABI) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/OABI

Underlying data: Yahoo Finance; company filings with the SEC.